STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[6-K] C21 Investments Inc. Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 or 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934

For the month of November 2025.

Commission File Number 000-55982

C21 INVESTMENTS INC.
(Translation of registrant’s name into English)

Suite 1900-855 West Georgia St
Vancouver BC, V6C 3H4
Canada
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F

Form 20-F [X]           Form 40-F [   ]


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

  C21 INVESTMENTS INC.
   
Date: November 11, 2025 /s/ Michael Kidd
  Michael Kidd
  Chief Financial Officer

-2-


INDEX TO EXHIBITS

Exhibit   Description
     
99.1   Interim Condensed Consolidated Financial Statements for the three and six months ended September 30, 2025 and 2024
99.2   Management’s Discussion and Analysis for the three and six months ended September 30, 2025
99.3   CEO Certification
99.4   CFO Certification


C21 Investments

OTC:CXXIF

CXXIF Rankings

CXXIF Latest News

CXXIF Latest SEC Filings

CXXIF Stock Data

36.53M
3.57M
12.35%
5.18%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Canada
Vancouver